2
Forward-Looking Statements
Statement contained in this presentation that are not based on historical fact, including without
limitation statements
containing
the
words
believes,
may,
plans,
will,
estimate,
continue,
anticipates,
intends,
expects
and
similar
expressions,
constitute
forward-looking
statements
within
the
meaning
of
the
U.S.
Private
Securities
Litigation
Reform
Act
of
1995 and forward-looking information within the meaning of applicable Canadian securities laws.
All such statements are
made
pursuant
to
the
safe
harbor
provisions
of
applicable
securities
legislation.
Forward-looking
statements
may
involve, but are
not limited to, comments with respect to our objectives and priorities for the second half of 2008
and beyond, our strategies or
future actions, our targets, expectations for our financial
condition and the results of, or outlook for, our operations, research,
development,
product and drug development and our plans and anticipated effects of the transaction described in this
presentation. Such forward-looking statements involve known and unknown risks, uncertainties and
other factors that may cause
the actual results, events or developments to be materially
different from any future results, events or developments expressed or
implied by such
forward-looking statements.
Many such risks, uncertainties and other factors are
taken into account as part of our assumptions underlying these forward-
looking
statements
and
include,
among
others,
the
following:
the
inability
to
consummate
the
transaction
described
in
this
presentation or that the transaction will not provide the anticipated benefits described in this
presentation; general economic and
business conditions, both nationally and in the
regions in which
we operate; market demand; technological changes that
could
impact
our
existing
products
or
our
ability
to
develop
and
commercialize
future
products;
competition;
existing
governmental regulations and changes in, or the failure to comply with, governmental regulations;
adverse results or unexpected
delays in pre-clinical and clinical product
development processes; adverse findings related to the safety and/or efficacy of our
products or products sold by our partners; decisions, and the timing of decisions, made by health
regulatory agencies regarding
approval of our technology and products; the requirement
for substantial funding to conduct research and development and to
expand manufacturing
and commercialization activities or consummate acquisitions; and any other factors that may affect
performance. In addition, our business is subject to certain operating risks that may cause the
actual results expressed or implied
by the forward-looking statements in this
presentation to differ materially from our actual results.
These
operating
risks
include:
our
ability
to
attract
and
retain
qualified
personnel;
our
ability
to
successfully
complete
pre-clinical
and clinical development of our products; changes in business strategy or development plans; our
failure to obtain patent
protection for discoveries; loss of patent protection resulting
from third-party challenges to our patents; commercialization
limitations imposed by
patents owned or controlled by third parties; our ability to obtain rights to
technology
from
licensors;
liability
for
patent
claims
and
other
claims
asserted
against
us;
our
ability
to
obtain
and
enforce
timely
patent
and
other
intellectual
property
protection
for
our
technology
and
products;
the
ability
to
enter
into,
and
to maintain,
corporate alliances relating to the development and commercialization of our technology and
products; market acceptance of our
technology and products; our ability to successfully
manufacture, market and sell our products; the
continued
availability
of
capital
to
finance
our
activities;
and
any
other
factors
referenced
in
our
other
filings
with
the
SEC.
For a
more
thorough
discussion
of
the
risks
associated
with
our
business,
see
the
Risk
Factors
section
in
our
annual
report
for the
year ended December 31, 2007 filed with the SEC on Form 40-F and our quarterly report for the
three months ended March 31,
2008 filed with the SEC on Form 10-Q.
Given
these
uncertainties,
assumptions
and
risk
factors,
readers
are
cautioned
not
to
place
undue
reliance
on
such
forward-
looking statements. Except as required by law, we disclaim any obligation to update any such factors
or to publicly announce the
result of any revisions to any of the forward-looking
statements contained in this presentation to reflect future results, events or
developments.
|